Despite considerable foreign exchange headwinds, Coloplast posted laudable fiscal third-quarter results that featured strength in interventional urology and wound care as non-pandemic procedures ...

Narrow-moat Coloplast posted fiscal first-quarter results that displayed underlying resiliency with organic growth consistent with our projections, and we’re standing pat on our fair value estimate.